Header

UZH-Logo

Maintenance Infos

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. Reply


Distler, Oliver; Gahlemann, Martina; Maher, Toby M (2019). Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. Reply. New England Journal of Medicine, 381(16):1596-1597.

Statistics

Citations

Dimensions.ai Metrics
8 citations in Web of Science®
1 citation in Scopus®
Google Scholar™

Altmetrics

Downloads

15 downloads since deposited on 08 Nov 2019
15 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Rheumatology Clinic and Institute of Physical Medicine
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > General Medicine
Language:English
Date:17 October 2019
Deposited On:08 Nov 2019 14:27
Last Modified:29 Jul 2020 11:39
Publisher:Massachusetts Medical Society
ISSN:0028-4793
OA Status:Green
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1056/NEJMc1910735
PubMed ID:31618556

Download

Green Open Access

Download PDF  'Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. Reply'.
Preview
Content: Published Version
Filetype: PDF
Size: 74kB
View at publisher